Medicare, Medicaid Drug Payment Models Get Designated Team At CMMI

14 Aug 2023

CMS’ innovation center creates new division to test alternative payment models, including likely new approaches for accelerated approval drugs and multi-state outcomes-based payment arrangements for cell and gene therapy in Medicaid.

The Centers for Medicare and Medicaid Services took a step toward developing innovative payment models specifically targeting prescription drugs with the recent formation of a new division within its Center for Medicare and Medicaid Innovation.

The new Drug Innovation Division will direct, design and implement models to “test alternative approaches to payment for drugs in...